175201-98-6 Usage
General Description
4-chloro-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxamide is a chemical compound with the molecular formula C10H9ClN4O. It is a pyrazolopyridine derivative, which means it contains a pyrazole and a pyridine ring. The compound has a chlorine atom attached to the fourth position of the pyrazole ring, and a carboxamide group at the fifth position. This chemical is often used as a building block in the synthesis of various pharmaceutical compounds, and is also being studied for its potential biological and pharmacological properties. Additionally, it is used for the synthesis of new anticancer agents.
Check Digit Verification of cas no
The CAS Registry Mumber 175201-98-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,2,0 and 1 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 175201-98:
(8*1)+(7*7)+(6*5)+(5*2)+(4*0)+(3*1)+(2*9)+(1*8)=126
126 % 10 = 6
So 175201-98-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H9ClN4O/c1-4-6-7(10)5(8(11)15)3-12-9(6)14(2)13-4/h3H,1-2H3,(H2,11,15)
175201-98-6Relevant articles and documents
New orally active PDE4 inhibitors with therapeutic potential
Ochiai, Hiroshi,Ishida, Akiharu,Ohtani, Tazumi,Kusumi, Kensuke,Kishikawa, Katuya,Obata, Takaaki,Nakai, Hisao,Toda, Masaaki
, p. 29 - 32 (2007/10/03)
Structural optimization of pyrazolopyridine derivative 2, which is one of the newly discovered chemical leads for PDE4 inhibitors from our in-house library, was carried out successfully. The process of discovery of new orally active PDE4 inhibitors, which
New orally active PDE4 inhibitors with therapeutic potential
Ochiai, Hiroshi,Ishida, Akiharu,Ohtani, Tazumi,Kusumi, Kensuke,Kishikawa, Katuya,Yamamoto, Susumu,Takeda, Hiroshi,Obata, Takaaki,Nakai, Hisao,Toda, Masaaki
, p. 4089 - 4100 (2007/10/03)
The design, synthesis, and biological evaluation of a series of pyrazolopyridines was carried out. Structural optimization of the aniline moiety of 4-anilinopyrazolopyridine derivative 3a, which is one of the newly discovered chemical leads for PDE4 inhib